|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis显示文摘 | Barton P Kalil AC Nadel S | 2004 | Pediatrics2004，113，11： | 1 |
| 2 | Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia显示文摘 | Berton D C Kalil A C Teixeira P J | 2014 | Cochrane Database Syst Rev2014，30，00： | 1 |
| 3 | Effects ofprolonged use of azithromycin in patients with cystic fibrosis : ameia-analysis 显示文摘 | FLORKSCU D F MURPHY P J KALIL A C | 2009 | Pulm Pharmacol Ther2009，22，6： | 1 |
| 4 | Safety,pharmacokinetics and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis显示文摘 | Barton P Kalil AC Nadel S | 2004 | Pediatrics2004，113，11： | 1 |
| 5 | New lead for in utero pacing for fetal congenital heart block 显示文摘 | Assad RS Zielinsky P Kalil R | 2003 | J Thorac Cardiovasc Surg2003，126，1： | 1 |
| 6 | Safety,pharmacokinetics,and pharmaco-dynamics of drotrecogin alfa(activated)in children with severe sepsis显示文摘 | Barton P Kalil A Nadel S | 2004 | Pediatrics2004，113，1： | 1 |
| 7 | Autoimmune responses to the brain after stroke are associated with worse outcome显示文摘 | Becker K J Kalil A J Tanzi P | 2011 | Stroke2011，42，10： | 1 |
| 8 | Post-Stroke infection: a role for IL-lra? 显示文摘 | Tanzi P Cain K Kalil A | 2011 | Neurocrit Care2011，14，2： | 1 |
| 9 | Effects of dietary vegeta- ble and marine lipid on growth, muscle fatty acid composi-tion and organoleptic quality of flesh of brookcharr (Salvelinusfontinalis) 显示文摘 | Guillou A Souey P Kalil M | 1995 | Aquaculture1995，136，： | 1 |
| 10 | The Montreal definintion and classification of gastroesophageal reflux disease:a globa evidence-based consensus显示文摘 | Vakil N van Zatcm SV Kalils P | 2014 | Am J Gastroenterol2014，101，： | 1 |
| 11 | Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated)in children with severe sepsis显示文摘 | Barton P Kalil AC Nadel S | 2004 | Pediatrics2004，113，1： | 1 |
| 12 | Effectiveness and safety of drotrecogin alia (activated) for severe sepsisz a meta- analysis and metaregression显示文摘 | Kalil A C LaRosa S P | 2012 | Lancet Infect Dis2012，12，9： | 1 |
| 13 | Conversion to a sirolimus-basedregimen is associatedwithlowerincidence of BK viremia in low-risk kidney transplant recipients显示文摘 | Tohme F A Kalil R S Thomas C P | 2015 | Transpl Infec Dis2015，17，1： | 1 |
| 14 | Safety,pharmacokinetics,and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis显示文摘 | Barton P Kalil AC Nadel S | 2004 | Pediatrics2004，113，11： | 1 |
| 15 | Increased expres- sion of tumor necrosis factor-alpha in diabetic macro- vasculopathy显示文摘 | Clausell N Kalil P Biolo A | 1999 | Cardiovasc Pathol1999，8，3： | 1 |
| 16 | Omalizumab administration in Churg-Strauss syndrome显示文摘 | Giavina-Bianchi P Kalil J | | 0，，： | 1 |
| 17 | Safety, pharmacokinetics and ppharmacodynamics of drotrecogin alfa ( activated ) in children with severe sepsis 显示文摘 | Barton P Kalil AC Nadel S | 2004 | Pediatrics2004，113，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员